Assessment of platelet function

Journal of Veterinary Emergency and Critical Care

Volumn 22, Issue 1, 2012, Pages 81-98

  Jandrey, Karl E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coagulation; Fibrin; Fibrinolysis; Hemostasis; Thrombosis; Von Willebrand

Indexed keywords

ANIMAL; ANIMAL DISEASE; BLOOD CLOTTING PARAMETERS; PHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOCYTE DISORDER;

ANIMALS; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; PLATELET FUNCTION TESTS;

ANIMALIA;

EID: 84864300057     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2011.00707.x     Document Type: Review

References (100)

1. Broos K, Hendrik BF, DeMeyer SF, et al. Platelets at work in primary hemostasis. Blood Rev 2011; 25(4):155-167.
2. Boudreaux MK. Acquired platelet dysfunction. In: Feldman BF, Zinkl JG, Jain NC. eds. Schalm's Veterinary Hematology, 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2000, pp. 496-500.
3. Catalfamo JL, Dodds WJ. Thrombopathias. In: Feldman BF, Zinkl JG, Jain NC. eds. Schalm's Veterinary Hematology, 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2000, pp. 1042-1050.
4. Zengin N, Enc N. Comparison of two blood sampling methods in anticoagulation therapy: venipuncture and peripheral venous catheter. J Clin Nurs 2008; 17(3):386-393.
5. Rioux JP, DeBortoli B, Quérin S, et al. Measurement of the international normalized ratio (INR) in hemodialysis patients with heparin-locked central venous catheters: evaluationof a novel blood sampling method. J Vasc Access 2009; 10(3):180-182.
6. Wills TB, Wardrop KJ. Pseudothrombocytopenia secondary to the effects of EDTA in a dog. J Am Anim Hosp Assoc 2008; 44(2):95-97.
7. Knoll JS. Clinical automated hematology systems. In: Feldman BF, Zinkl JG, Jain NC. eds. Schalm's Veterinary Hematology, 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2000, pp. 10.
8. Tvedten H, Grabski S, Frame L. Estimating platelets and leukocytes on canine blood smears. Vet Clin Pathol 1988; 17(1):4-6.
9. Hackner SG. Bleeding disorders. In: Silverstein DC, Hopper K. eds. Small Animal Critical Care Medicine. St. Louis, MO: Saunders/Elsevier; 2009, pp. 511.
10. Bertazzolo W, Comazzi S, Sesso L, et al. Comparison of methods for determining platelet numbers and volume in Cavalier King Charles spaniels. J Small Anim Pract 2007; 48(10):556-561.
11. Tvedten H. What is your diagnosis? Discrepancy in platelet counts determined using a Sysmex XT-2000 iV hematology analyzer. Vet Clin Pathol 2010; 39(3):395-396.
12. Cole EH. Hemostasis and coagulation of blood. In: Cole EH edr. Veterinary Clinical Pathology. Philadelphia, PA: W.B.Saunders; 1980, pp. 152.
13. Nicholson NS, Panzer-Knodle SG, Haas NF, et al. Assessment of platelet function assays. Am Heart J 1998; 135(5):S170-S178.
14. Harrison P, Mumford A. Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Semin Thromb Hemost 2009; 35(2):150-157.
15. Parker MT, Collier LL, Kier AB, et al. Oral mucosa bleeding times of normal cats and cats with Chediak-Higashi syndrome of Hageman Trait (Factor XII deficiency). Vet Clin Pathol 1988; 17(1):9-12.
16. Hogan DF, Andrews DA, Green HW, et al. Antiplatelet effects and pharmacodynamics of clopidogrel in cats. J Am Vet Med Assoc 2004; 225(9):1406-1411.
17. Jergens AE, Turrentine MA, Kraus KH, et al. Buccal mucosal bleeding times of healthy dogs and dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand's disease. Am J Vet Res 1987; 48(9):1337-1342.
18. Marks SL. The buccal mucosal bleeding time. J Am Anim Hosp Assoc 2000; 36(4):289-290.
19. Chohan AS, Greene SA, Grubb TL, et al. Effects of 6% hetastarch (600/0.75) or lactated Ringer's solution on hemostatic variables and clinical bleeding in healthy dogs anesthetized for orthopedic surgery. Vet Anesth Analg 2011; 38(2):94-105.
20. Wu AHB, Lewandrowski K, Gronowski AM, et al. Antiquated tests within the clinical pathology laboratory. Am J Manag Care 2010; 16(9):e220-e227.
21. Posan E, McBane RD, Grill DE, et al. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thromb Haemost 2003; 90(3):483-490.
22. Kratzer MA, Born GV. Simulation of primary haemostasis in vitro. Haemostasis 1985; 15(6):357-362.
23. Mammen EF, Alshameeri RS, Comp PC. Preliminary data from a field trial of the PFA-100® system. Semin Thromb Hemost 1995; 21(S2):113-121.
24. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost 1995; 21(S2):106-112.
25. Joutsi-Korhonen L, Smethurst PA, Rankin A, et al. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 2003; 101(11):4372-4379.
26. Hermans C, Wittevrongel C, Thys C, et al. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. J Thromb Haemost 2009; 7(8):1356-1363.
27. Brooks MB, Randolph J, Warner K, et al. Evaluation of platelet function screening tests to detect platelet procoagulant deficiency in dogs with Scott syndrome. Vet Clin Pathol 2009; 38(3):306-315.
28. Callan MB, Giger U. Effect of desmopressin acetate administration on primary hemostasis in Doberman Pinschers with type-1 von Willebrand disease as assessed by a point-of-care instrument. Am J Vet Res 2002; 63(12):1700-1706.
29. Mischke R, Keidel A. Influence of platelet count, acetylsalicylic acid, von Willebrand's disease, coagulopathies, and haematocrit on results obtained using a platelet function analyzer in dogs. Vet J 2003; 165(1):43-52.
30. Wierenga JR, Jandrey KE, Haskins SC, et al. In vitro comparison of the effects of two forms of hydroxyethyl starch solutions on platelet function in dogs. Am J Vet Res 2007; 68(6):605-609.
31. Smart L, Jandrey KE, Kass PH, et al. The effect of hetastarch (670/0.75) in vivo on platelet closure time in the dog. J Vet Emerg Crit Care 2009; 19(5):444-449.
32. Keidel A, Mischke R. Untersuchungen zur klinischen anwendung des plättchenfunktionsanalysengerätes PFA-100 beim hund [Clinical evaluation of platelet function analyzer PFA-100 in dogs]. Berl Münch Tierärztl Wschr 1998; 111(11-12):452-456.
33. Escudero C, Santos M, Buján J, et al. Optical aggregometry versus the PFA-100™: experimental studies in pigs treated with propofol. Platelets 2001; 12(3):133-137.
34. Segura A, Monreal L, Espada Y, et al. Assessment of a platelet function analyzer in horses: reference range and influence of a platelet aggregation inhibitor. Vet J 2005; 170(1):108-112.
35. Jandrey KE, Norris JW, MacDonald KA, et al. Platelet function in clinically healthy cats and cats with hypertrophic cardiomyopathy: analysis using the Platelet Function Analyzer-100. Vet Clin Pathol 2008; 37(4):385-388.
36. Clancey N, Burton S, Horney B, et al. Effects of in vitro hemodilution of canine blood on platelet function analysis using the PFA-100. Vet Clin Pathol 2009; 38(4):467-470.
37. Tarnow I, Kristensen AT, Texel H, et al. Decreased platelet function in Cavalier King Charles Spaniels with mitral valve regurgitation. J Vet Intern Med 2003; 17(5):680-686.
38. Clancey N, Burton S, Horney B, et al. Evaluation of platelet function in dogs with cardiac disease using the PFA-100 platelet function analyzer. Vet Clin Pathol 2009; 38(3):299-305.
39. Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost 2008; 34(8):709-733.
40. Carr ME. In vitro assessment of platelet function. Transfus Med Rev 1997; 11(2):106-115.
41. Breddin HK. Can platelet aggregometry be standardized? Platelets 2005; 16(3/4):151-158.
42. Brainard BM, Kleine SA, Papich MG, et al. Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs. Am J Vet Res 2010; 71(7):822-830.
43. Brainard BM, Meredith CP, Callan MB, et al. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res 2007; 68(3):251-257.
44. Hayward CPM, Moffat KA, Raby A et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol 2010; 134(6):955-963.
45. Cardinal J, Flower R. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3(2):135-158.
46. Velik-Salchner C, Maier S, Innerhofer P, et al. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study. Anesth Analg 2008; 107(6):1798-1806.
47. Michelson AD. Methods for the measurement of platelet function. Am J Cardiol 2009; 103(3Suppl):20A-26A.
48. Kalbantner K, Baumgarten A, Mischke R. Measurement of platelet function in dogs using a novel impedance aggregometer. Vet J 2010; 185(2):144-151.
49. Bochsen L, Johansson PI, Kristensen AT, et al. The influence of platelets, plasma and red blood cells on functional haemostatic assays. Blood Coagul Fibrinolysis 2011; 22(3):167-175.
50. McNeil EA, Ogilvie GK, Fettman MJ, et al. Platelet hyperfunction in dogs with malignancies. J Vet Intern Med 1997; 11(3):178-182.
51. Helenski CA, Ross JN. Platelet aggregation in feline cardiomyop-athy. J Vet Intern Med 1987; 1(1):24-28.
52. Guillaumin J, Jandrey KE, Norris JW, et al. Assessment of a dimethyl sulfoxide-stabilized frozen canine platelet concentrate. Am J Vet Res 2008; 69(12):1580-1586.
53. Guillaumin J, Jandrey KE, Norris JW, et al. Analysis of a commercial dimethyl sulfoxide-stabilized frozen canine platelet concentrate by turbidometric aggregometry. J Vet Emerg Crit Care 2010; 20(6):571-577.
54. Van Werkum JW, Harmsze AM, Elsenberg EHAM, et al. The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence. Platelets 2008; 19(7):479-488.
55. Varon D, Dardik R, Shenkman B, et al. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997; 85(4):283-294.
56. Shenkman B, Savion N, Dardik R, et al. Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor. Thromb Res 2000; 99(4):353-361.
57. Varon D, Savion N. Impact cone and plate(let) analyzer. In: Michelson AD. ed. Platelets, 2nd ed. Burlington, MA: Academic Press/Elsevier; 2007, pp. 535-544.
58. Morrison A, Hornsey VS, Prowse CV, et al. Use of the DiaMed Impact R to test platelet function in stored platelet concentrates. Vox Sang 2007; 93(2):166-172.
59. Peerschke EIB, Silver RT, Weksler B, et al. Ex vivo evaluation of erythrocytosis-enhanced platelet thrombus formation using the cone and plate(let) analyzer: effect of platelet agonists. Br J Haematol 2004; 127(2):195-203.
60. Peerschke EIB, Silver RT, Weksler B, et al. Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer. Am J Clin Pathol 2007; 127(3):422-428.
61. Spectre G, Brill A, Gural A, et al. A new point-of-care method for monitoring anti-platelet therapy: application of the cone and plate(let) analyzer. Platelets 2005; 16(5):293-299.
62. Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent artherothrombotic events in patients with acute myocardial infarction. Circulation 2004; 109(25):3171-3175.
63. Van Werkum JW, Bouman HJ, Breet NJ, et al. The cone and plate(let) analyzer is not suitable to monitor clopidogrel therapy: a comparison with the flowcytometric VASP assay and optical aggregometry. Thromb Res 2010; 126(1):44-49.
64. Wang X, Dorsam RT, Lauver A, et al. Comparative analysis of various platelet glycoprotein IIb/IIIa antagonists on shear-induced platelet activation and adhesion. J Pharmacol Exp Ther 2002; 303(3):1114-1120.
65. McMichael MA, Smith SA. Viscoelastic coagulation testing: technology, applications, and limitations. Vet Clin Pathol 2011; 40(2):1-14.
66. Von Kaulla KN, Ostendorf P, von Kaulla E. The impedance machine: a new bedside coagulation recording device. J Med 1975; 6(1):73-88.
67. Hett DA, Walker SN, Pilkington SN, et al. Sonoclot analysis. Br J Anaesth 1995; 75(6):771-776.
68. Dallap Shaer BL, Wilkins PA, Boston R, et al. Preliminary evaluation of hemostasis in neonatal foals using a viscoelastic coagulation and platelet function analyzer. J Vet Emerg Crit Care 2009; 19(1):81-87.
69. Dallap Shaer BL, Bentz AI, Boston R, et al. Comparison of viscoelastic coagulation analysis and standard coagulation profiles in critically ill neonatal foals to outcome. J Vet Emerg Crit Care 2009; 19(1):88-95.
70. Hartert H. Blutgerinnungsstudien mit der thromboelastographie, einen neuen untersuchungsverfahren [Coagulation analysis with thromboelastography, a new method]. Klin Wochenschr 1948; 26(37-38):577-583.
71. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106(5):1366-1375.
72. Chen A, Teruya J. Global hemostasis testing thromboelastography: old technology, new applications. Clin Lab Med 2009; 29(2):391-407.
73. Kol A, Borjesson DL. Application of thromboelastography/thromboelastometry to veterinary medicine. Vet Clin Pathol 2010; 39(4):405-416.
74. Jackson GNB, Ashpole KJ, Yentis SM. The TEG® and the ROTEM® thromboelastography/thromboelastometry systems. Anaesth 2009; 64(2):212-215.
75. Chitlur M, Sorensen B, Rivard GE, et al. Standardization of thromboelastography: a report from the TEG-ROTEM work group. Haemophilia 2011; 17(3):532-537.
76. Paltrinieri S, Meazza C, Giordano A, Tunesi C. Validation of thromboelastometry in horses. Vet Clin Pathol 2008; 37(3):277-285.
77. Callan MB Aljamali MN, Margaritis P, et al. A novel missense mutation responsible for factor VII deficiency in research Beagle colonies. J Thromb Haemost 2006: 4(12):2616-2622.
78. Smith SA, McMichael MA, Galligan A, et al. Clot formation in canine whole blood measured by rotation al thromboelastometry is influenced by sample handling and coagulation activator. Blood Coagul Fibrinolysis 2010; 21(7):692-702.
79. Epstein KL, Brainard BM, Gomez-Ibanez SE, et al. Thromboelastography in horses with acute gastrointestinal disease. J Vet Intern Med 2011; 25(2):307-314.
80. Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005; 34(4):389-393.
81. Kristensen AT, Wiinberg B, Jessen L, et al. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008; 22(1):140-147.
82. Jessen LR, Wiinberg B, Jensen AL, et al. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time. Vet Clin Pathol 2008; 37(4):363-372.
83. Marschner CB, Bjørnvad CR, Kristensen AT, et al. Thromboelastography results on citrated whole blood from clinically healthy cats depend on modes of activation. Acta Vet Scand 2010; 52:38. Available at: Accessed April 15, 2011.
84. Dai Y, Lee A, Critchey LAH, White PF. Does thromboelastography predict postoperative thrombotic events? A systematic review of the literature. Anesth Analg 2009; 108(3):734-742.
85. Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217(10):1500-1504.
86. Wiinberg B, Jensen AL, Johansson PI, et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008; 22(2):357-365.
87. Wiinberg B, Jensen AL, Rozanski E, et al. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. Vet J 2009; 179(1):121-129.
88. Wagg CR, Boysen SR, Bédard C. Thromboelastography in dogs admitted to an intensive care unit. Vet Clin Pathol 2009; 38(4):453-461.
89. Klose TC, Creevy KE, Brainard BM. Evaluation of coagulation status in dogs with naturally occurring canine hyperadrenocorticism. J Vet Emerg Crit Care. 2011; 21(6):625-632.
90. Epstein KL, Brainard BM, Lopes MAF, et al. Thromboelastography in 26 horses with and without activation by recombinant human tissue factor. J Vet Emerg Crit Care 2009; 19(1):96-101.
91. Mendez-Angulo JL, Mudge MC, Vilar-Saavedra P, et al. Thromboelastography in healthy horses and horses with inflammatory gastrointestinal disorders and suspected coagulopathies. J Vet Emerg Crit Care 2010; 20(5):498-493.
92. Dunkel B, Chan DL, Boston R, et al. Association between hypercoagulability and decreased survival in horses with ischemic or inflammatory gastrointestinal disease. J Vet Intern Med 2010; 24(6):1467-1474.
93. Alwood AJ, Downend AB, Brooks MB, et al. Anticoagulant effects of low-molecular-weight heparins in healthy cats. J Vet Intern Med 2008; 21(3):378-387.
94. Sinnott VB, Otto CM. Use of thromboelastography in dogs with immune-mediated hemolytic anemia. J Vet Emerg Crit Care 2009; 19(5):484-488.
95. Fenty RK, deLaforcade AM, Shaw SP, et al. Identification of hypercoagulability in dogs with immune-mediated hemolytic anemia by means of thromboelastography. J Am Vet Med Assoc 2011; 239(4):463-467.
96. Goodwin LV, Goggs R, Chan DL, et al. Hypercoagulabilty in dogs with protein-losing enteropathy. J Vet Intern Med 2011; 25(2):273-277.
97. Pittman JR, Koenig A, Brainard BM. The effect of unfractionated heparin on thromboelastographic analysis in healthy dogs. J Vet Emerg Crit Care 2010; 20(2):216-223.
98. Linden MD, Frelinger AL, Barnard MR, et al. Application of flow cytometry to platelet disorders. Semin Thromb Hemost 2004; 30(5):501-511.
99. Michelson AD, Linden MD, Barnard MR, et al. Flow cytometry. In: Michelson AD. ed. Platelets, 2nd ed. Burlington, MA: Academic Press/Elsevier; 2007, pp. 545-563.
100. McKenzie ME, Gurbel PA, Levine DJ, et al. Clinical utility of available methods for determining platelet function. Cardiology 1999; 92(4):240-247.